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Diagram of pairSEQ experiment. A pre-determined number of T cells are distributed between wells of a 96-well plate. 
The mRNA in each well in then extracted and cDNA is synthesized and amplified by primers that are specific to the T-
cell receptor genes. Well-specific barcodes allows for pooled sequencing and a computational framework maps each 
TCRA or TCRB sequence to its original well. Pairs of TCRA and TCRB sequences that share occupancy patterns are 
inferred to have come from the same T-cell clone. 
Image from the publication. 
T cells, a major subtype of white blood cells, are key to harnessing the potential of the immune 
system to fight cancer and other diseases. Current cancer immunotherapies seek to expand or 
reengineer T cells with the best cancer-fighting prowess. However, identifying the right T cell clones 
(a T-cell and all of its descendants) can be time and labor-intensive. T cells recognize their target 
cancer cell or pathogen through a T cell receptor (TCR), composed of two polypeptides, an α chain 
and a β chain. To identify T cell lineages it is important to know the identity of both the α and β 
sequences and which α and β chains pair together. Previous work from Dr. Harlan Robins (Public 
Health Sciences and Human Biology Divisions), and his collaborators at Adaptive Biotechnologies, 
developed a high throughput assay called immunoSEQ to sequence individual α and β chains. 
However, without resorting to single-cell methods, which are not easily scalable, it had not been 
previously possible to know which α and β chains occur together. Dr. Robins’ team has now 
developed and validated a clever high-throughput way of identifying α and β chain pairs, which 
enables reconstitution of specific TCRs for functional assays and therapeutic applications. This study 
was recently published in Science Translational Medicine. 
"We have spent many years sequencing single chains of the T cell receptor, which has allowed us to 
track individual T cells and develop diagnostics.  With this new technology, we can sequence the full 
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TCR (both chains paired together) at high throughput.  This allows us to recreate the TCR for 
functional studies as well therapeutic use," said Dr. Robins. The α and β chains are encoded by two 
separate genes: TCRA (α) and TCRB (β). Because both TCRA and TCRB experience genetic 
rearrangements during T-cell development, their mRNA sequences are unique for each T-cell clone. 
The investigators thus reasoned that the TCRA and TCRB from a T-cell clone could be identified by 
first dividing a T-cell sample into different subsets, and then by tracking which TCRA and TCRB 
sequences co-occur in the same subsets. Each subset harbored a barcode, which enable the 
amplified receptor to be pooled for high-throughput sequencing. To validate their new method, called 
pairSEQ, the authors sequenced the TCRA and TCRB from 1 million peripheral blood mononuclear 
cells (PBMCs) from two healthy adults. The two samples were mixed in a single plate and the 
pairSEQ computational framework correctly assigned more than 3200 TCRA/TCRB pairs with less 
than 30 errors. Next, the authors asked whether pairSEQ could identify rare T-cell clones by 
increasing the number of T-cells per well (160,000), and they identified more than 362,528 TCR 
pairs at a false discovery rate of 1%, including 26,667 with frequencies of 1 in a million or lower. 
Finally, the researchers asked whether pairSEQ could be used to interrogate samples other than 
blood, such as tumor-infiltrating lymphocytes (TILs) present in solid tumors. To this end, they 
obtained samples from nine solid tumors and matched blood samples. As before, the authors first 
sequenced the TCRA and TCRB repertoires from each sample to determine how many cells to use 
for the pairSEQ assay. They then ran the pairSEQ assay on dissociated tumor cells as well as the 
PBMCs. The pairSEQ algorithm assigned 6172 pairs from the tumor sample and 14,123 from 
PBMCs, while maintaining an FDR of 1%. In summary, pairSEQ can accurately identify TCR pairs in 
multiple sample types and across a range of clonal frequencies using standard laboratory 
equipment, and therefore will have broad applicability in biomedical research.  
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